Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Interictal type 1 cannabinoid receptor binding is increased in female migraine patients.

Van der Schueren BJ, Van Laere K, Gérard N, Bormans G, De Hoon JN.

Headache. 2012 Mar;52(3):433-40. doi: 10.1111/j.1526-4610.2011.02030.x. Epub 2011 Nov 11.

PMID:
22077199
2.

Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET.

Van Laere K, Goffin K, Casteels C, Dupont P, Mortelmans L, de Hoon J, Bormans G.

Neuroimage. 2008 Feb 15;39(4):1533-41. Epub 2007 Nov 13.

PMID:
18077184
3.

Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa.

Gérard N, Pieters G, Goffin K, Bormans G, Van Laere K.

Biol Psychiatry. 2011 Oct 15;70(8):777-84. doi: 10.1016/j.biopsych.2011.05.010. Epub 2011 Jun 29.

PMID:
21718968
4.

An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam.

Goffin K, Bormans G, Casteels C, Bosier B, Lambert DM, Grachev ID, Van Paesschen W, Van Laere K.

Neuropharmacology. 2008 Jun;54(7):1103-6. doi: 10.1016/j.neuropharm.2008.02.018. Epub 2008 Mar 10.

PMID:
18423778
5.

Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament.

Van Laere K, Goffin K, Bormans G, Casteels C, Mortelmans L, de Hoon J, Grachev I, Vandenbulcke M, Pieters G.

Arch Gen Psychiatry. 2009 Feb;66(2):196-204. doi: 10.1001/archgenpsychiatry.2008.530.

PMID:
19188542
6.

Influence of chronic nicotine administration on cerebral type 1 cannabinoid receptor binding: an in vivo micro-PET study in the rat using [18F]MK-9470.

Gérard N, Ceccarini J, Bormans G, Vanbilloen B, Casteels C, Goffin K, Bosier B, Lambert DM, Van Laere K.

J Mol Neurosci. 2010 Oct;42(2):162-7. doi: 10.1007/s12031-010-9340-2. Epub 2010 Feb 25.

PMID:
20182818
7.

Prenatal poly I:C age-dependently alters cannabinoid type 1 receptors in offspring: a longitudinal small animal PET study using [(18)F]MK-9470.

Verdurand M, Dalton VS, Nguyen V, Grégoire MC, Zahra D, Wyatt N, Burgess L, Greguric I, Zavitsanou K.

Exp Neurol. 2014 Jul;257:162-9. doi: 10.1016/j.expneurol.2014.05.004. Epub 2014 May 10.

PMID:
24825369
8.

[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.

Burns HD, Van Laere K, Sanabria-Bohórquez S, Hamill TG, Bormans G, Eng WS, Gibson R, Ryan C, Connolly B, Patel S, Krause S, Vanko A, Van Hecken A, Dupont P, De Lepeleire I, Rothenberg P, Stoch SA, Cote J, Hagmann WK, Jewell JP, Lin LS, Liu P, Goulet MT, Gottesdiener K, Wagner JA, de Hoon J, Mortelmans L, Fong TM, Hargreaves RJ.

Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9800-5. Epub 2007 May 29.

9.

Kinetic analysis of the cannabinoid-1 receptor PET tracer [(18)F]MK-9470 in human brain.

Sanabria-Bohórquez SM, Hamill TG, Goffin K, De Lepeleire I, Bormans G, Burns HD, Van Laere K.

Eur J Nucl Med Mol Imaging. 2010 May;37(5):920-33. doi: 10.1007/s00259-009-1340-5. Epub 2009 Dec 24.

PMID:
20033684
10.

Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study.

Ceccarini J, Casteels C, Koole M, Bormans G, Van Laere K.

Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1582-94. doi: 10.1007/s00259-013-2456-1. Epub 2013 Jun 6.

PMID:
23740372
11.

A positron emission tomographic study in spontaneous migraine.

Afridi SK, Giffin NJ, Kaube H, Friston KJ, Ward NS, Frackowiak RS, Goadsby PJ.

Arch Neurol. 2005 Aug;62(8):1270-5.

PMID:
16087768
12.

Interictal metabolic changes in episodic migraine: a voxel-based FDG-PET study.

Kim JH, Kim S, Suh SI, Koh SB, Park KW, Oh K.

Cephalalgia. 2010 Jan;30(1):53-61. doi: 10.1111/j.1468-2982.2009.01890.x.

PMID:
19489887
13.

In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease.

Casteels C, Lauwers E, Baitar A, Bormans G, Baekelandt V, Van Laere K.

Brain Res. 2010 Feb 26;1316:153-62. doi: 10.1016/j.brainres.2009.12.026. Epub 2009 Dec 21.

PMID:
20026090
14.

Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects.

Van Laere K, Koole M, Sanabria Bohorquez SM, Goffin K, Guenther I, Belanger MJ, Cote J, Rothenberg P, De Lepeleire I, Grachev ID, Hargreaves RJ, Bormans G, Burns HD.

J Nucl Med. 2008 Mar;49(3):439-45. doi: 10.2967/jnumed.107.047290. Epub 2008 Feb 20.

15.

The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain.

Casteels C, Bormans G, Van Laere K.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1164-73. doi: 10.1007/s00259-010-1383-7. Epub 2010 Feb 25.

PMID:
20182714
16.

Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use.

Liu P, Lin LS, Hamill TG, Jewell JP, Lanza TJ Jr, Gibson RE, Krause SM, Ryan C, Eng W, Sanabria S, Tong X, Wang J, Levorse DA, Owens KA, Fong TM, Shen CP, Lao J, Kumar S, Yin W, Payack JF, Springfield SA, Hargreaves R, Burns HD, Goulet MT, Hagmann WK.

J Med Chem. 2007 Jul 26;50(15):3427-30. Epub 2007 Jul 3.

PMID:
17608398
17.

PET imaging studies in rhesus monkey with the cannabinoid-1 (CB1) receptor ligand [11C]CB-119.

Hamill TG, Lin LS, Hagmann W, Liu P, Jewell J, Sanabria S, Eng W, Ryan C, Fong TM, Connolly B, Vanko A, Hargreaves R, Goulet MT, Burns HD.

Mol Imaging Biol. 2009 Jul-Aug;11(4):246-52. doi: 10.1007/s11307-008-0194-8. Epub 2009 Jan 7.

PMID:
19130142
18.

Voxel-based morphometry reveals gray matter abnormalities in migraine.

Valfrè W, Rainero I, Bergui M, Pinessi L.

Headache. 2008 Jan;48(1):109-17. doi: 10.1111/j.1526-4610.2007.00723.x.

PMID:
18184293
19.

Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence.

Ceccarini J, Hompes T, Verhaeghen A, Casteels C, Peuskens H, Bormans G, Claes S, Van Laere K.

J Neurosci. 2014 Feb 19;34(8):2822-31. doi: 10.1523/JNEUROSCI.0849-13.2014.

20.

Interictal brain 5-HT1A receptors binding in migraine without aura: a 18F-MPPF-PET study.

Lothe A, Merlet I, Demarquay G, Costes N, Ryvlin P, Mauguière F.

Cephalalgia. 2008 Dec;28(12):1282-91. doi: 10.1111/j.1468-2982.2008.01677.x. Epub 2008 Aug 22.

PMID:
18727636
Items per page

Supplemental Content

Write to the Help Desk